BamSEC and AlphaSense Join Forces
Learn More

LadRx Corp

OTC: LADX    
Share price (11/22/24): $0.80    
Market cap (11/22/24): $396 thousand

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 425 65 pages Agreement and Plan of Merger Dated as of June 6, 2008 Among Innovive Pharmaceuticals, Inc., CytRx Corporation, Cytrx Merger Subsidiary, Inc. and Steven Kelly
12/34/56
EX-2.1
from 8-K 65 pages Agreement and Plan of Merger Dated as of June 6, 2008 Among Innovive Pharmaceuticals, Inc., CytRx Corporation, Cytrx Merger Subsidiary, Inc. and Steven Kelly
12/34/56
EX-2.1
from 10-K405 ~50 pages Agreement & Plan of Merger
12/34/56
EX-2.5
from S-1/A 1 page Letter Agreement Dated 11-22-00
12/34/56
EX-2.1
from S-1/A ~20 pages Private Equity Line of Credit Agreement
12/34/56
EX-2.1
from 8-K ~5 pages Purchase Agreement
12/34/56
EX-2.4
from S-1 ~10 pages Stock Purchase Warrant
12/34/56
EX-2.3
from S-1 ~5 pages Escrow Agreement
12/34/56
EX-2.2
from S-1 ~10 pages Registration Rights Agreement
12/34/56
EX-2.1
from S-1 ~20 pages Private Equity Line of Credit Agreement
12/34/56
EX-2.1
from 8-K ~10 pages Stock Acquisition Agreement, Dated June 2, 1999
12/34/56
EX-2.1
from 8-K >50 pages Acquisition Agreement/April 17,1998
12/34/56
EX-2.5
from 8-K ~10 pages Securities Agreement Cytrx and David Kosloff
12/34/56
EX-2.4
from 8-K ~10 pages Securities Agreement Cytrx and Charles Eckert
12/34/56
EX-2.3
from 8-K ~10 pages Securities Agreement Cytrx and Pine Street
12/34/56
EX-2.2
from 8-K ~10 pages Securities Agreement Cytrx and Excalibur
12/34/56
EX-2.1
from 8-K ~10 pages Securities Agreement Cytrx and Gundyco
12/34/56
EX-2.2
from 8-K ~10 pages Preferred Stock & Warrant Agreement
12/34/56
EX-2.1
from 8-K >50 pages Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K >50 pages Agreement and Plan of Merger
12/34/56